Federal Drug Patent Grab Means Fewer New Medicines: Think Tank (1)

Fewer new medicines would come onto the market if the NIH exercised its rights to commandeer drug patents as a way of combating high drug prices, according to a think tank.

The report released March 4 from the Information Technology and Innovation Foundation (ITIF) is a win for the drug industry, which continues to face criticism on Capitol Hill for the rising costs of prescription drugs. Lawmakers and the White House are considering a number of policy options to bring down drug prices, and the use of National Institutes of Health funds in drug development has come up ...